Literature DB >> 27468749

Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice.

Lei Wang1, Helmut Hiller1, Justin A Smith1, Annette D de Kloet2, Eric G Krause3.   

Abstract

This study tested the hypothesis that deletion of angiotensin type 1a receptors (AT1a) from the paraventricular nucleus of hypothalamus (PVN) attenuates anxiety-like behavior, hypothalamic-pituitary-adrenal (HPA) axis activity, and cardiovascular reactivity. We used the Cre/LoxP system to generate male mice with AT1a specifically deleted from the PVN. Deletion of the AT1a from the PVN reduced anxiety-like behavior as indicated by increased time spent in the open arms of the elevated plus maze. In contrast, PVN AT1a deletion had no effect on HPA axis activation subsequent to an acute restraint challenge but did reduce hypothalamic mRNA expression for corticotropin-releasing hormone (CRH). To determine whether PVN AT1a deletion inhibits cardiovascular reactivity, we measured systolic blood pressure, heart rate, and heart rate variability (HRV) using telemetry and found that PVN AT1a deletion attenuated restraint-induced elevations in systolic blood pressure and elicited changes in HRV indicative of reduced sympathetic nervous activity. Consistent with the decreased HRV, PVN AT1a deletion also decreased adrenal weight, suggestive of decreased adrenal sympathetic outflow. Interestingly, the altered stress responsivity of mice with AT1a deleted from the PVN was associated with decreased hypothalamic microglia and proinflammatory cytokine expression. Collectively, these results suggest that deletion of AT1a from the PVN attenuates anxiety, CRH gene transcription, and cardiovascular reactivity and reduced brain inflammation may contribute to these effects.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  anxiety; corticosterone; corticotropin-releasing hormone; neuroinflammation; stress

Mesh:

Substances:

Year:  2016        PMID: 27468749      PMCID: PMC5111882          DOI: 10.1152/physiolgenomics.00029.2016

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  72 in total

1.  Neural mechanisms subserving central angiotensinergic influences on plasma renin in sheep.

Authors:  M J McKinley; M I McBurnie; M L Mathai
Journal:  Hypertension       Date:  2001-06       Impact factor: 10.190

2.  Cardiovascular and metabolic responses to fasting and thermoneutrality in Ay mice.

Authors:  T D Williams; J B Chambers; S P Gagnon; L M Roberts; R P Henderson; J M Overton
Journal:  Physiol Behav       Date:  2003-04

3.  Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress.

Authors:  Peter Blandino; Christopher J Barnum; Lyvia G Solomon; Yaniv Larish; Benjamin S Lankow; Terrence Deak
Journal:  Brain Behav Immun       Date:  2009-05-21       Impact factor: 7.217

4.  Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats.

Authors:  Walter Raasch; Christian Wittmershaus; Andreas Dendorfer; Inga Voges; Friedrich Pahlke; Christoph Dodt; Peter Dominiak; Olaf Jöhren
Journal:  Endocrinology       Date:  2006-03-30       Impact factor: 4.736

5.  Angiotensinergic neurotransmission in the paraventricular nucleus of the hypothalamus modulates the pressor response to acute restraint stress in rats.

Authors:  C Busnardo; R F Tavares; F M A Correa
Journal:  Neuroscience       Date:  2014-04-06       Impact factor: 3.590

6.  Antagonism of cannabinoid 1 receptors reverses the anxiety-like behavior induced by central injections of corticotropin-releasing factor and cocaine withdrawal.

Authors:  D A Kupferschmidt; A E Newman; R Boonstra; S Erb
Journal:  Neuroscience       Date:  2011-07-14       Impact factor: 3.590

7.  Interleukin-1β causes anxiety by interacting with the endocannabinoid system.

Authors:  Silvia Rossi; Lucia Sacchetti; Francesco Napolitano; Valentina De Chiara; Caterina Motta; Valeria Studer; Alessandra Musella; Francesca Barbieri; Monica Bari; Giorgio Bernardi; Mauro Maccarrone; Alessandro Usiello; Diego Centonze
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

8.  Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against diet-induced obesity.

Authors:  Annette D de Kloet; Dipanwita Pati; Lei Wang; Helmut Hiller; Colin Sumners; Charles J Frazier; Randy J Seeley; James P Herman; Stephen C Woods; Eric G Krause
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

9.  Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier.

Authors:  Vinicia Campana Biancardi; Sook Jin Son; Sahra Ahmadi; Jessica A Filosa; Javier E Stern
Journal:  Hypertension       Date:  2013-12-16       Impact factor: 10.190

10.  Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation.

Authors:  Michio Miyoshi; Kanako Miyano; Naoki Moriyama; Makoto Taniguchi; Tatsuo Watanabe
Journal:  Eur J Neurosci       Date:  2008-01-11       Impact factor: 3.386

View more
  13 in total

1.  A Unique "Angiotensin-Sensitive" Neuronal Population Coordinates Neuroendocrine, Cardiovascular, and Behavioral Responses to Stress.

Authors:  Annette D de Kloet; Lei Wang; Soledad Pitra; Helmut Hiller; Justin A Smith; Yalun Tan; Dani Nguyen; Karlena M Cahill; Colin Sumners; Javier E Stern; Eric G Krause
Journal:  J Neurosci       Date:  2017-02-20       Impact factor: 6.167

2.  (Pro)renin receptor knockdown in the paraventricular nucleus of the hypothalamus attenuates hypertension development and AT1 receptor-mediated calcium events.

Authors:  Lucas A C Souza; Caleb J Worker; Wencheng Li; Fatima Trebak; Trevor Watkins; Ariana Julia B Gayban; Evan Yamasaki; Silvana G Cooper; Bernard T Drumm; Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 4.733

3.  Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice.

Authors:  Lei A Wang; Annette D de Kloet; Michael D Smeltzer; Karlena M Cahill; Helmut Hiller; Erin B Bruce; David J Pioquinto; Jacob A Ludin; Michael J Katovich; Mohan K Raizada; Eric G Krause
Journal:  Neuropharmacology       Date:  2018-05-01       Impact factor: 5.250

4.  Angiotensin AT1A receptors expressed in vasopressin-producing cells of the supraoptic nucleus contribute to osmotic control of vasopressin.

Authors:  Jeremy A Sandgren; Danny W Linggonegoro; Shao Yang Zhang; Sarah A Sapouckey; Kristin E Claflin; Nicole A Pearson; Mariah R Leidinger; Gary L Pierce; Mark K Santillan; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-01-24       Impact factor: 3.619

5.  Blood-borne interleukin-1β acts on the subfornical organ to upregulate the sympathoexcitatory milieu of the hypothalamic paraventricular nucleus.

Authors:  Shun-Guang Wei; Yang Yu; Robert B Felder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-22       Impact factor: 3.619

6.  Aberrant DNA methylation of hypothalamic angiotensin receptor in prenatal programmed hypertension.

Authors:  Fumiko Kawakami-Mori; Mitsuhiro Nishimoto; Latapati Reheman; Wakako Kawarazaki; Nobuhiro Ayuzawa; Kohei Ueda; Daigoro Hirohama; Daisuke Kohno; Shigeyoshi Oba; Tatsuo Shimosawa; Takeshi Marumo; Toshiro Fujita
Journal:  JCI Insight       Date:  2018-11-02

7.  Caspase lesions of PVN-projecting MnPO neurons block the sustained component of CIH-induced hypertension in adult male rats.

Authors:  Alexandria B Marciante; Lei A Wang; Joel T Little; J Thomas Cunningham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-01       Impact factor: 4.733

Review 8.  Brain Angiotensin Type-1 and Type-2 Receptors in Physiological and Hypertensive Conditions: Focus on Neuroinflammation.

Authors:  Khalid Elsaafien; Annette D de Kloet; Eric G Krause; Colin Sumners
Journal:  Curr Hypertens Rep       Date:  2020-07-13       Impact factor: 5.369

Review 9.  GABA is a mediator of brain AT1 and AT2 receptor-mediated blood pressure responses.

Authors:  Alain G Dupont; Laura Légat
Journal:  Hypertens Res       Date:  2020-05-25       Impact factor: 3.872

Review 10.  Hypothalamic GPCR Signaling Pathways in Cardiometabolic Control.

Authors:  Yue Deng; Guorui Deng; Justin L Grobe; Huxing Cui
Journal:  Front Physiol       Date:  2021-06-28       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.